Cargando…
Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study
OBJECTIVES: To understand stakeholders’ perceptions of the access barriers to quality-assured diagnostics and medicines for leishmaniasis in the high-burden region of eastern Africa, and to identify key bottlenecks to improve the supply of commodities for neglected tropical diseases. DESIGN: Desk re...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549606/ https://www.ncbi.nlm.nih.gov/pubmed/31152044 http://dx.doi.org/10.1136/bmjopen-2019-029141 |
_version_ | 1783424042158522368 |
---|---|
author | Sunyoto, Temmy Potet, Julien den Boer, Margriet Ritmeijer, Koert Postigo, Jose A R Ravinetto, Raffaella Alves, Fabiana Picado, Albert Boelaert, Marleen |
author_facet | Sunyoto, Temmy Potet, Julien den Boer, Margriet Ritmeijer, Koert Postigo, Jose A R Ravinetto, Raffaella Alves, Fabiana Picado, Albert Boelaert, Marleen |
author_sort | Sunyoto, Temmy |
collection | PubMed |
description | OBJECTIVES: To understand stakeholders’ perceptions of the access barriers to quality-assured diagnostics and medicines for leishmaniasis in the high-burden region of eastern Africa, and to identify key bottlenecks to improve the supply of commodities for neglected tropical diseases. DESIGN: Desk reviews and qualitative in-depth interview study with purposive sampling. METHODS: A landscape analysis through literature and desk review was performed. Next, 29 representatives from international organisations, non-governmental agencies, national control programmes from six countries (Ethiopia, Kenya, Somalia, South Sudan, Sudan and Uganda) and manufacturers were interviewed between May and July 2018. Participants were selected purposively and expanded through a snowballing technique. Data analysis was aided by NVivo, applying the framework method as a part of the thematic content analysis approach. RESULTS: The barriers along the visceral leishmaniasis (VL) supply chain were identified as emerging themes, grouped across supply chain activities and health systems component(s). Stakeholders expressed the perception of progress, but bottlenecks persist. VL medicines, in general, lack multisource production capacity and with small market volume, expansion of suppliers is difficult. Procurement is plagued by forecasting difficulties, complex regulatory policies and procedures, and distribution challenges. Weak communication and coordination across different levels resulted in shortages and loss of trust among different actors. Cross-cutting issues spanned from limited political and resource commitment due to low awareness and limited in-country capacity. However, study respondents were optimistic to pursue several remedies, most importantly to build bridges between supply and demand sides through continued dialogue and collaborations. Diagnostics supply has mostly been overlooked; thus, improved investment in this area is needed. CONCLUSIONS: Addressing supply barriers in eastern Africa requires consistent, specific efforts at the global and national levels, progressing from current partnerships and agreements. Priority actions include pooled procurement, improved forecast, and increased commitment and resources. Sustainability remains an elusive goal, yet to be integrated into discussions moving forward. |
format | Online Article Text |
id | pubmed-6549606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-65496062019-06-21 Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study Sunyoto, Temmy Potet, Julien den Boer, Margriet Ritmeijer, Koert Postigo, Jose A R Ravinetto, Raffaella Alves, Fabiana Picado, Albert Boelaert, Marleen BMJ Open Qualitative Research OBJECTIVES: To understand stakeholders’ perceptions of the access barriers to quality-assured diagnostics and medicines for leishmaniasis in the high-burden region of eastern Africa, and to identify key bottlenecks to improve the supply of commodities for neglected tropical diseases. DESIGN: Desk reviews and qualitative in-depth interview study with purposive sampling. METHODS: A landscape analysis through literature and desk review was performed. Next, 29 representatives from international organisations, non-governmental agencies, national control programmes from six countries (Ethiopia, Kenya, Somalia, South Sudan, Sudan and Uganda) and manufacturers were interviewed between May and July 2018. Participants were selected purposively and expanded through a snowballing technique. Data analysis was aided by NVivo, applying the framework method as a part of the thematic content analysis approach. RESULTS: The barriers along the visceral leishmaniasis (VL) supply chain were identified as emerging themes, grouped across supply chain activities and health systems component(s). Stakeholders expressed the perception of progress, but bottlenecks persist. VL medicines, in general, lack multisource production capacity and with small market volume, expansion of suppliers is difficult. Procurement is plagued by forecasting difficulties, complex regulatory policies and procedures, and distribution challenges. Weak communication and coordination across different levels resulted in shortages and loss of trust among different actors. Cross-cutting issues spanned from limited political and resource commitment due to low awareness and limited in-country capacity. However, study respondents were optimistic to pursue several remedies, most importantly to build bridges between supply and demand sides through continued dialogue and collaborations. Diagnostics supply has mostly been overlooked; thus, improved investment in this area is needed. CONCLUSIONS: Addressing supply barriers in eastern Africa requires consistent, specific efforts at the global and national levels, progressing from current partnerships and agreements. Priority actions include pooled procurement, improved forecast, and increased commitment and resources. Sustainability remains an elusive goal, yet to be integrated into discussions moving forward. BMJ Publishing Group 2019-05-30 /pmc/articles/PMC6549606/ /pubmed/31152044 http://dx.doi.org/10.1136/bmjopen-2019-029141 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Qualitative Research Sunyoto, Temmy Potet, Julien den Boer, Margriet Ritmeijer, Koert Postigo, Jose A R Ravinetto, Raffaella Alves, Fabiana Picado, Albert Boelaert, Marleen Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study |
title | Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study |
title_full | Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study |
title_fullStr | Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study |
title_full_unstemmed | Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study |
title_short | Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study |
title_sort | exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern africa: a qualitative study |
topic | Qualitative Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549606/ https://www.ncbi.nlm.nih.gov/pubmed/31152044 http://dx.doi.org/10.1136/bmjopen-2019-029141 |
work_keys_str_mv | AT sunyototemmy exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy AT potetjulien exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy AT denboermargriet exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy AT ritmeijerkoert exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy AT postigojosear exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy AT ravinettoraffaella exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy AT alvesfabiana exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy AT picadoalbert exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy AT boelaertmarleen exploringglobalandcountrylevelbarrierstoaneffectivesupplyofleishmaniasismedicinesanddiagnosticsineasternafricaaqualitativestudy |